Caligor Coghlan Pharma Services
Drug Stores & Pharmacies · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1500 Business Park Dr Unit B, Bastrop, T...Phone Number
(512) 303-1265Website
www.calcog.comRevenue
$15 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
2
1
About Caligor Coghlan Pharma Services
Caligor Coghlan Pharma Services is global provider of pharma services to assist in the development to commercialization of pharmaceutical, biotechnology, and medical device assets. Services include clinical trial design, clinical and commercial packaging and labeling, IMP management and distribution, comparator and ancillary procurement, Clinical Supply Management, Early Access to Medicines services, global Regulatory consulting, commercialized product distribution, and asset acquisition planning. The company operates facilities in Bastrop, TX, USA, and Dartford, UK.Explore more
Caligor Coghlan Pharma Services Org Chart
TJ
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Caligor Coghlan Pharma Services your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Caligor Coghlan Pharma Services, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Caligor Coghlan Pharma Services had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Caligor Coghlan Pharma Services
Funding: Get notified immidiatlly once Caligor Coghlan Pharma Services has new funding data
Product Launch: Get notified when Caligor Coghlan Pharma Services launches new products
Earning: See what the market has to say on Caligor Coghlan Pharma Services recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Caligor Coghlan Pharma Services is spiking on competitors!
Check if Caligor Coghlan Pharma Services has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Caligor Coghlan Pharma Services
Find 2 more new buyers
Compare Similar Companies to Caligor Coghlan Pharma Services
Compare insights from companies similar to Caligor Coghlan Pharma Services, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Caligor Coghlan Pharma Se...
$15M
51-200
Private
-
1996
SS
Shana SeelhorstCorporate Accounting Controller & Acting Chief Financial Officer
Company Profile Activity
Activity Insights
Caligor Coghlan Pharma Services is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Caligor Coghlan Pharma Services is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Caligor Coghlan Pharma Services.
Caligor Coghlan Pharma Services Tech Stack
A closer look at the technologies used by Caligor Coghlan Pharma Services
Most Recent Scoops
Open Position
Open Position
Funding
Caligor Coghlan Pharma Services has received an SBA PPP loan for $350,000-1 million from Texas Capital Bank, supporting the retention of 23 jobs.
Funding
Caligor Coghlan Pharma Services News & Media
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World
NEW YORK, Aug. 11, 2020 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it is launching a Named Patient Program for its non-opioid bone metastases pain palliation drug, Strontium89 (Strontium Chloride Sr-89 Injection, USP). The Named...Q BioMed, Inc. CEO Discusses Recently Announced Global Distribution Partnership with Caligor Coghlan Pharma Services in Audio Interview with SmallCapVoice.com
AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial stage biotech company, CEO Denis Corin, who discusses the development of the Company’s exclusive Named Patient Program distribution agreement for its non-opioid metastatic cancer bone pain drug, Strontium89, with Caligor Coghlan Pharma Services (CCPS) for the ex-U.S. marketGlobal Clinical Trial Packaging Market 2020-2024 | Evolving Opportunities With Bilcare Ltd. and Caligor Coghlan Pharma Services | Technavio
LONDON--(BUSINESS WIRE)-- #Biotechnology--The global clinical trial packaging market is poised to grow by USD 667.92 million during 2020-2024, progressing at a CAGR of more than 4%.
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Caligor Coghlan Pharma Services
Sign Up For FreeTo access detailed company insights
Caligor Coghlan Pharma Services is global provider of pharma services to assist in the development to commercialization of pharmaceutical, biotechnology, and medical device assets. Services include clinical trial design, clinical and commercial packaging and labeling, IMP management and distribution, comparator and ancillary procurement, Clinical S... Read More
